DA Davidson raises Salesforce stock price target on platform strategy

DA Davidson raised Salesforce's price target to $225 from $200 but retained a Neutral rating, leaving estimates unchanged; CRM traded at $250.54, already above the new target. The firm remains cautious on organic-growth reacceleration but expects healthy EPS growth from cost synergies, supported by Salesforce's 77% gross margin. Separately, Salesforce reiterated its fiscal 2030 target of $63 billion in revenue, implying an 11% CAGR and at least a 39% operating margin, while several analysts cited potential upside from AI product monetization and improved bookings.

Analysis

The relevant signal is not the target change but the refusal to raise estimates after customer and partner meetings while the stock trades above the revised valuation framework. That creates near-term multiple-compression risk: CRM’s premium AI monetization narrative requires bookings conversion into subscription revenue, yet cost discipline can support EPS even if top-line growth does not reaccelerate. In a market rewarding AI revenue proof rather than product announcements, an unchanged revenue model is a negative read-through for the next 1-3 months.

Margin execution makes an outright structural short unattractive. CRM can protect earnings, free cash flow and buyback capacity through operating leverage, while a durable improvement in large-enterprise bookings would move the debate quickly from margins to revenue duration and support a higher multiple over 6-18 months. The principal second-order risk is to implementation partners such as ACN and GLOB: slower CRM seat expansion or longer AI deployment cycles would defer high-margin consulting utilization, even if CRM’s own software margins remain resilient.

Consensus appears too focused on the long-dated revenue and margin algorithm and too little on the adoption bottleneck: AI features must displace existing software budgets or demonstrate labor savings sufficient to overcome procurement scrutiny. The stock likely needs independently observable evidence—remaining-performance-obligation acceleration, current-RPO growth, net-new Agentforce/AI contract value, and stable renewal rates—before a sustained rerating is justified. A material upward revision to forward revenue estimates, rather than another price-target increase, would falsify the cautious tactical view.

Key Decisions for Investors

• Do not add directional CRM exposure ahead of the next earnings release solely on conference commentary; maintain a watch trigger for current-RPO or remaining-performance-obligation growth accelerating by at least 2 percentage points and management raising the next-fiscal revenue outlook. Those data are required before underwriting an AI-driven rerating.
• For a 1-3 month tactical position, consider a defined-risk CRM put spread centered around the $225-$230 area, funded only if implied volatility is not already elevated; the thesis is that unchanged estimates force the share price toward the analyst valuation anchor. Exit if CRM closes decisively above $270 or if verified AI bookings drive consensus revenue upgrades.
• Pair a modest long CRM / short ACN or GLOB only after CRM demonstrates bookings acceleration but implementation demand remains soft: CRM captures software gross margin while services firms bear utilization risk from delayed deployments. Reassess following each company’s bookings, headcount and utilization disclosures.
• Over a 6-18 month horizon, accumulate CRM only on a post-earnings selloff if operating-margin delivery remains intact and net retention/renewal metrics hold; the favorable asymmetry is margin-supported free cash flow versus a temporary delay in AI revenue. Avoid this long thesis if management cuts the long-term revenue framework or renewal pressure emerges in large enterprise accounts.